Sarda Proteins Ltd.

As of March 31, 2026, Sarda Proteins Ltd. carries a market capitalization of 758.28M, placing it among publicly traded companies globally. Its enterprise value stands at 683.09M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Sarda Proteins Ltd. has 8.98M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Sarda Proteins Ltd. maintains a current ratio of 288.13, meaning it holds 288.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on September 18, 2026, Sarda Proteins Ltd.'s stock has gained approximately 5.07% over the past 52 weeks. The 50-day moving average sits at 87.84, while the 200-day moving average is 87.02.

As of March 31, 2026, Sarda Proteins Ltd. holds 75.19M in cash and equivalents against - - in total debt, resulting in a net debt position of -75.19M. Total book value stands at 862.07M, with working capital of 840.72M providing operational flexibility.